Medical cannabis trial to target 20,000 UK patients
Project Twenty21 will test seven medical conditions including chronic pain
Up to 20,000 patients are to be given medicinal cannabis in the first large-scale clinical trial of the drug.
Project Twenty21, which will measure the drug’s impact on seven medical conditions, will subsidise cannabis for thousands of patients by the end of 2021, and is backed by the Royal College of Psychiatrists.
The trial is aiming to “create the largest body of evidence on medical cannabis in Europe”, according to The Guardian, with the hope that it will convince policymakers that “the drug should be made as widely available, and affordable, as other approved prescription medications”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It will study the drug’s effects on patients who have either chronic pain, epilepsy, multiple sclerosis, post-traumatic stress disorder, Tourette’s syndrome, anxiety disorder or who have had a history of substance misuse. Across the UK, 28 million people are estimated to suffer from chronic pain.
What is the law on medicinal cannabis in the UK?
Although medical cannabis was legalised in the UK a year ago, it remains unobtainable for many patients, according to campaigners.
Since legalisation, NHS doctors have rarely prescribed the drug because of “a lack of evidence about its efficacy”, according to the Guardian.
“There are also fears it is being over-hyped by a nascent industry focused on maximising profit,” the newspaper adds.
Sky News reports that medical authorities have said that there is only a “paucity of evidence” that medicinal cannabis works.
This means that the only option for patients is to “source cannabis illegally, and risk prosecution, or pay for a private prescription of the drug”, Sky News says.
The BBC reports that one family from Cardiff pays around £4,000 a month for medicinal cannabis, as it is not available to them on the NHS. The drug is used to treat their 17-year-old son who has a rare form of epilepsy.
What is the reaction to the trial?
Sky News reports that while the trial is the largest of its kind, it will have to overcome “medical scepticism”, after the clinical watchdog NICE said that cannabis should not be prescribed for a range of conditions, including chronic pain.
However, Professor David Nutt of the organisation Drug Science, the charity running the trial, said that cannabis can be “life-saving” in certain cases, for example severe childhood epilepsy.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Get your first six issues free–––––––––––––––––––––––––––––––
Nutt said: “I believe cannabis is going to be the most important innovation in medicine for the rest of my life.
“There are children who have died in this country in the last couple of years because they haven’t had access to cannabis. It’s outrageous, it’s unnecessary and we want to rectify it.”
Nutt is a former government adviser and has worked on the misuse of drugs in the Ministry of Defence, Department of Health and the Home Office.
He was dismissed from his post as a government adviser in 2009, after the publication of a pamphlet that contained elements of a lecture he had given on the relative harm caused by illicit drugs.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
'Making a police state out of the liberal university'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
8 looming climate tipping points that imperil our planet
The Explainer New reports detail the thresholds we may be close to crossing
By Devika Rao, The Week US Published
-
Try 6 free issues of The Week Junior
Spark your child's curiosity with The Week Junior - the award-winning current affairs magazine for 8-14s.
By The Week Published
-
Immunotherapy and hay fever
The Explainer Research shows that the treatment could provide significant relief from symptoms for many hay fever sufferers
By Richard Windsor, The Week UK Published
-
Pros and cons of universal health care
Pros and Cons A medical system that serves everyone comes with its own costs, and they're not only financial
By Rebecca Messina, The Week UK Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
Martha's Rule: patients given right to urgent second opinion
The Explainer Hospitals in England will launch new scheme that will allow access to a rapid treatment review
By Richard Windsor, The Week UK Published
-
The contaminated blood scandal
The Explainer Widely regarded as the worst treatment disaster in the history of the NHS, the public inquiry is due to publish its report in May
By The Week UK Published
-
Can Britain's dental crisis be fixed?
The Explainer New proposals include more money for dentists working in under-served areas
By Richard Windsor, The Week UK Published
-
Tianeptine: why lawmakers fear a new kind of opioid
The explainer The drug is sold over the counter. And is highly addictive.
By Devika Rao, The Week US Published